The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.
November 21st 2024
Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
fMRI documents risk anticipation center in the brain
March 15th 2005You’re doing 50 mph in a 35 mph zone. Suddenly, out of the corner of your eye, you notice what look like the black-and-white markings of a police car. Your heart rate speeds up, and you automatically take your foot off the gas pedal. The anterior cingulate cortex region in the brain may have prompted that speedy reaction, according to researchers at Washington University in St. Louis.
Prostate imagers await 3T endorectal coils
March 6th 2005Under the best of circumstances, 3T imaging of the prostate with a body coil can approximate the level of detail and sensitivity available at 1.5T with an endorectal coil. Researchers hope that with a 3T-oriented endorectal coil they will finally be able to take advantage of 3T's higher resolution in a challenging portion of the anatomy.
MR contrast agent improves liver imaging, allows cholangiography
March 5th 2005Primovist improves MR detection of liver lesions and can change the surgical management of patients in a substantial number of cases, according to the results of two studies presented at the ECR Friday. The data were part of a symposium sponsored by Schering, the developer of the liver-specific agent.
Post-treatment imaging offers precise tracking of rectal cancer recurrence
March 4th 2005Despite advances in the diagnosis and treatment of rectal cancer, five-year survival rates continue to hover around the 50% mark. For cancers limited to the bowel wall, however, the survival rate climbs to 83%, highlighting the importance of early detection and treatment. Almost all rectal cancers are primary adenocarcinomas, and 90% of them occur after the age of 50.
Federal imaging proposals mesh with ACR initiatives
March 4th 2005RADPAC, the American College of Radiology's political fundraising arm, rated among the top five health industry political action committees in terms of financial contributions last year, having bestowed nearly $1 million in the last election cycle. If this is any indication of the ACR's pull on Capitol Hill, the landscape for diagnostic imaging could look vastly different as Congress debates controversial proposals aimed at curbing the rising cost of imaging.
Intraoperative high-field MR revamps neurosurgery
March 4th 2005The introduction of high-field MR systems for intraoperative guidance brings neurointervention to new levels. Although it is pricey and complex compared with previous technology, high-field MR may eventually prove cost-effective by helping neurosurgeons achieve better results, reduce patient complications, and cultivate partnerships with other specialists through better scanner utilization.
Software, coil advances promise to broaden MR mammography
March 4th 2005MR mammography benefits from the reputation of its cornerstone modality's ability to detect soft-tissue abnormalities, particularly cancer. And it presents the opportunity for patients to avoid the discomfort of breast compression.
ECR Webcast showcases latest research
March 3rd 2005For the third year running, editors from Diagnostic Imaging have landed in Vienna to provide Webcast coverage of the European Congress of Radiology. Although the RSNA is becoming more international every year, it can’t capture the unique European perspective presented at this annual event. Our daily news stories will highlight research from the studies presented at the ECR, but much more is available at the Webcast.
Growing demand for 3T MR raises safety concerns in U.K.
February 28th 2005The wider use of 3T MR scanners, combined with the increasing number of patients with implants, is prompting concern among regulators in the U.K. They question the compatibility of new-generation scanners and medical implants.
Patients breathe easy with bile duct imaging technique
February 10th 2005Free-breathing 3D MR sequences using the prospective acquisition correction with navigator echoes (PACE) technique can successfully image patients with biliary and/or pancreatic diseases, according to researchers at St. Louis University Hospital.
Screening centers skew ads to favor benefits
February 8th 2005Whole-body screening centers fail to provide balanced advertisements, often touting unsupported benefits while downplaying known risks. Although not calling for federal legislation, researchers say the industry needs better oversight to protect consumers.
CT leads imaging field in plaque assessment
February 7th 2005CT is moving beyond detection and quantification of coronary artery calcium to grading of coronary stenoses, identifying not only vulnerable plaques but, more important, vulnerable patients. Yet its ultimate role in predicting risk of cardiac events remains unclear.
Report from SCMR: Late-enhancement MR predicts susceptibility to future cardiac death
January 25th 2005The prognostic value of cardiac MR was a prominent theme last week at the Society for Cardiovascular Magnetic Resonance meeting in San Francisco. Dr. Rishi Kaushal, a CMR researcher at the University of California, Los Angeles, presented results demonstrating that myocardial infarction size measured with cine and delayed-enhancement MR can predict the risk of mortality posed by the injury.
MR contrast patterns predict breast cancer therapy response
January 11th 2005The permeability of gadolinium and the morphology of breast cancer can reliably predict whether those tumors will benefit from neoadjuvant chemotherapy, according to research presented at the San Antonio Breast Cancer Symposium in December.
Transesophageal MRI shows early plaque reduction
January 7th 2005Faster MR gradients, improved surface coil designs, and the use of an intraesophageal antenna functioning as an additional receiver have enabled researchers to document atherosclerotic plaque regression within six months of statin therapy. Previous MR technology could verify the same response only after a year of drug treatment.
Vivid imaginations trigger false memories
January 6th 2005Imagine you are asked to discern between two groups of images. You are told that half contain cancerous lesions and half do not. The methodology of the study may already be flawed because of the way the brain creates false memories after leading questions or directions.